BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 19254674)

  • 1. The prevalence and impact of anergia (lack of energy) in subjects with heart failure and its associations with actigraphy.
    Maurer MS; Cuddihy P; Weisenberg J; Delisle S; Strong BM; Gao Q; Kachnowski S; Howell J
    J Card Fail; 2009 Mar; 15(2):145-51. PubMed ID: 19254674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accelerometer-Measured Daily Activity in Heart Failure With Preserved Ejection Fraction: Clinical Correlates and Association With Standard Heart Failure Severity Indices.
    Snipelisky D; Kelly J; Levine JA; Koepp GA; Anstrom KJ; McNulty SE; Zakeri R; Felker GM; Hernandez AF; Braunwald E; Redfield MM
    Circ Heart Fail; 2017 Jun; 10(6):e003878. PubMed ID: 28588021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quality of life in heart failure with preserved ejection fraction: importance of obesity, functional capacity, and physical inactivity.
    Reddy YNV; Rikhi A; Obokata M; Shah SJ; Lewis GD; AbouEzzedine OF; Dunlay S; McNulty S; Chakraborty H; Stevenson LW; Redfield MM; Borlaug BA
    Eur J Heart Fail; 2020 Jun; 22(6):1009-1018. PubMed ID: 32150314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Maximum daily 6 minutes of activity: an index of functional capacity derived from actigraphy and its application to older adults with heart failure.
    Howell J; Strong BM; Weisenberg J; Kakade A; Gao Q; Cuddihy P; Delisle S; Kachnowski S; Maurer MS
    J Am Geriatr Soc; 2010 May; 58(5):931-6. PubMed ID: 20374397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relation of depression to severity of illness in heart failure (from Heart Failure And a Controlled Trial Investigating Outcomes of Exercise Training [HF-ACTION]).
    Gottlieb SS; Kop WJ; Ellis SJ; Binkley P; Howlett J; O'Connor C; Blumenthal JA; Fletcher G; Swank AM; Cooper L;
    Am J Cardiol; 2009 May; 103(9):1285-9. PubMed ID: 19406273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemodynamic-guided heart-failure management using a wireless implantable sensor: Infrastructure, methods, and results in a community heart failure disease-management program.
    Jermyn R; Alam A; Kvasic J; Saeed O; Jorde U
    Clin Cardiol; 2017 Mar; 40(3):170-176. PubMed ID: 27878990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quality of life questionnaire predicts poor exercise capacity only in HFpEF and not in HFrEF.
    Ahmeti A; Henein MY; Ibrahimi P; Elezi S; Haliti E; Poniku A; Batalli A; Bajraktari G
    BMC Cardiovasc Disord; 2017 Oct; 17(1):268. PubMed ID: 29041912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vitamin D deficiency in patients with diastolic dysfunction or heart failure with preserved ejection fraction.
    Nolte K; Herrmann-Lingen C; Platschek L; Holzendorf V; Pilz S; Tomaschitz A; Düngen HD; Angermann CE; Hasenfuß G; Pieske B; Wachter R; Edelmann F
    ESC Heart Fail; 2019 Apr; 6(2):262-270. PubMed ID: 30784226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence, clinical characteristics, quality of life, and prognosis of patients with congestive heart failure and isolated left ventricular diastolic dysfunction.
    Badano LP; Albanese MC; De Biaggio P; Rozbowsky P; Miani D; Fresco C; Fioretti PM
    J Am Soc Echocardiogr; 2004 Mar; 17(3):253-61. PubMed ID: 14981424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and characteristics of anergia (lack of energy) in patients with acute coronary syndrome.
    Shaffer JA; Davidson KW; Schwartz JE; Shimbo D; Newman JD; Gurland BJ; Maurer MS
    Am J Cardiol; 2012 Nov; 110(9):1213-8. PubMed ID: 22835409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heart Failure Severity and Quality of Warfarin Anticoagulation Control (From the WARCEF Trial).
    Lee TC; Qian M; Lip GYH; Di Tullio MR; Graham S; Mann DL; Nakanishi K; Teerlink JR; Freudenberger RS; Sacco RL; Mohr JP; Labovitz AJ; Ponikowski P; Lok DJ; Estol C; Anker SD; Pullicino PM; Buchsbaum R; Levin B; Thompson JLP; Homma S; Ye S;
    Am J Cardiol; 2018 Sep; 122(5):821-827. PubMed ID: 30037426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Baroreflex Activation Therapy in Patients With Heart Failure With Reduced Ejection Fraction.
    Zile MR; Lindenfeld J; Weaver FA; Zannad F; Galle E; Rogers T; Abraham WT
    J Am Coll Cardiol; 2020 Jul; 76(1):1-13. PubMed ID: 32616150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adaptive servo-ventilation to treat central sleep apnea in heart failure with reduced ejection fraction: the Bad Oeynhausen prospective ASV registry.
    Oldenburg O; Wellmann B; Bitter T; Fox H; Buchholz A; Freiwald E; Horstkotte D; Wegscheider K
    Clin Res Cardiol; 2018 Aug; 107(8):719-728. PubMed ID: 29654439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Additive prognostic value of subjective assessment with respect to clinical cardiological data in patients with chronic heart failure.
    Majani G; Pierobon A; Pinna GD; Giardini A; Maestri R; La Rovere MT
    Eur J Cardiovasc Prev Rehabil; 2011 Dec; 18(6):836-42. PubMed ID: 21450593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rest-activity rhythms, daytime symptoms, and functional performance among people with heart failure.
    Jeon S; Conley S; Redeker NS
    Chronobiol Int; 2020 Aug; 37(8):1223-1234. PubMed ID: 32588662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Self-reported lack of energy (anergia) among elders in a multiethnic community.
    Cheng H; Gurland BJ; Maurer MS
    J Gerontol A Biol Sci Med Sci; 2008 Jul; 63(7):707-14. PubMed ID: 18693225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Health-Related Quality of Life in Heart Failure With Preserved Ejection Fraction: The PARAGON-HF Trial.
    Chandra A; Vaduganathan M; Lewis EF; Claggett BL; Rizkala AR; Wang W; Lefkowitz MP; Shi VC; Anand IS; Ge J; Lam CSP; Maggioni AP; Martinez F; Packer M; Pfeffer MA; Pieske B; Redfield MM; Rouleau JL; Van Veldhuisen DJ; Zannad F; Zile MR; McMurray JJV; Solomon SD;
    JACC Heart Fail; 2019 Oct; 7(10):862-874. PubMed ID: 31302043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac contractility modulation improves long-term survival and hospitalizations in heart failure with reduced ejection fraction.
    Anker SD; Borggrefe M; Neuser H; Ohlow MA; Röger S; Goette A; Remppis BA; Kuck KH; Najarian KB; Gutterman DD; Rousso B; Burkhoff D; Hasenfuss G
    Eur J Heart Fail; 2019 Sep; 21(9):1103-1113. PubMed ID: 30652394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Variable Contribution of Heart Failure to Quality of Life in Ambulatory Heart Failure With Reduced, Better, or Preserved Ejection Fraction.
    Joyce E; Chung C; Badloe S; Odutayo K; Desai A; Givertz MM; Nohria A; Lakdawala NK; Stewart GC; Young M; Weintraub J; Stevenson LW; Lewis EF
    JACC Heart Fail; 2016 Mar; 4(3):184-93. PubMed ID: 26874379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contributions of Comorbid Diabetes to Sleep Characteristics, Daytime Symptoms, and Physical Function Among Patients With Stable Heart Failure.
    Fritschi C; Redeker NS
    J Cardiovasc Nurs; 2015; 30(5):411-9. PubMed ID: 25078876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.